| 000 | 01424 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516045921.0 | ||
| 264 | 0 | _c20110815 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(11)61100-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarge, Dominique | |
| 245 | 0 | 0 |
_aAutologous HSCT in systemic sclerosis: a step forward. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cAug 2011 |
||
| 300 |
_a460-2 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEarly Termination of Clinical Trials |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xdrug therapy |
| 650 | 0 | 4 | _aTherapeutic Equipoise |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGluckman, Eliane | |
| 773 | 0 |
_tLancet (London, England) _gvol. 378 _gno. 9790 _gp. 460-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(11)61100-8 _zAvailable from publisher's website |
| 999 |
_c21024958 _d21024958 |
||